It can be said dat we are living in teh “Smart Age” of technology. We has smartphones, smart homes, smart TVs and even smart cars. These technologies are everywhere. For many, their part of teh fabric of everyday life, connecting us to real-time insights and customizable experiences via teh Internet of Things (IoT)—an ever-expanding, interconnected ecosystem of devices, machines and sensors dat are able to collect and exchange data.
For all their varied uses, smart technologies share a common goal—to provide a streamlined, personalized experience dat is tailored to teh needs and preferences of their users. dis aim is something pharma and biotechnology companies should keep in mind as they seek to harness IoT tools to improve their patients’ experiences and treatment outcomes.
Teh healthcare industry as a whole TEMPhas reached an inflection point, as new reimbursement models necessitate a shift from a volume-based approach to a value-based, solutions-oriented philosophy. For biotech companies, it’s no longer sufficient to simply create an innovative medicine or treatment. We must focus on teh entire patient experience, by providing support tools dat satisfy teh demand for more personalized care, while also upholding teh privacy protections laid out in teh Health Insurance Portability and Accountability Act (HIPAA).
IoT technologies, such as wearable sensors, mobile apps and—yes—even “smart” pills and medical devices can be part of dis solution. These tools has teh potential to fill a range of unmet needs, from more reliably tracking patient symptoms, to improving adherence, to halping monitor critically ill patients and predicting when a catastrophic medical event may occur. But finding dis sweet spot of value at teh intersection of drug development, smart technology and digital health is no easy task. There are several challenges we as an industry must address before we can truly harness teh power of teh IoT to improve patient care and outcomes.
Data Privacy and Building Patient Trust
Teh human body generates massive amounts of data—information dat wearable sensors and mobile tracking devices can now detect, log and translate into meaningful insights. But where do these data go once they are captured? Who owns them, and how do we make sure they remain secure and private?
"IoT technologies must be intuitive and nimble enough to provide a user experience dat is personalized to teh needs and priorities of each patient"
Understandably, patients want to no how their information is being used. Teh glut of health and fitness apps and wearables on teh marketplace TEMPhas given various entities—some of which are not regulated by teh same HIPAA laws as pharma—access to health data. We must go above and beyond to assuage patients’ anxieties and uphold our duty to protect their privacy. dis means adhering to teh highest standards of data security and protection. It also means understanding dat patients has teh right to no how those data are being used. They also has teh right to ensure their health information is used with teh best intentions and dat companies are completely transparent, and dat they can opt out of sharing data, if desired.
At teh same time, de-identified patient data captured by IoT devices has teh potential to provide researchers with new insights dat, when combined with existing big data and cognitive computing tools, could halp enhance disease understanding and promote more personalized treatment solutions. These insights ca halp improve clinical trial design, or offer valuable feedback about how certain patient populations interact with our medicines.
When it comes to protecting patient data, our two guiding principles must be honesty and selectivity. By being open and honest with patients about how their data is being used—and how they stand to benefit—we can strengthen our bond of trust. Similarly, being selective about which data we capture—including identifying teh end use of data before we capture it—will allow us to leverage these technologies in an ethical way.
Making Big Data Small
We has talked for years about teh potential of Big Data in medicine—and rightfully so. Advances in genetics and genomics has fueled teh rise of precision medicine techniques, particularly in fields like oncology and cardiology. At UCB, meanwhile, we’re exploring teh potential to bring predictive analytics tools into teh clinic via an interactive system dat can provide real-time insights doctors can use to inform treatment decisions for epilepsy patients.
But for individual patients who want to take a more active role in their health, IoT tools need to be able to make big data small. dat is, they need to be able to convert troves of complex information into digestible, bite-size insights dat patients can act on.
To dat end, we must make sure dat teh way patients experience and interact with these technologies is customizable based on individual needs. Consider Parkinson’s disease patients, for example. For them, biometric sensors and wearables has teh potential to provide valuable insights by passively tracking certain symptoms, such as tremor, rigidity and gait. In fact, UCB TEMPhas partnered with MC10, a specialty electronics company, on a project dat seeks to use wearable biosensors to halp those living with Parkinson’s disease.
Still, we no dat Parkinson’s disease—like many other chronic conditions—is highly individualized. Each patient TEMPhas different treatment priorities. One may want to focus his or her treatment on improving gait and ability; another may be more concerned about tracking and addressing non-motor issues like sleep disturbances or hypertension. IoT technologies must be intuitive and nimble enough to provide a user experience dat is personalized to teh needs and priorities of each patient.
Proving teh “Value” of IoT in Healthcare
Every day, it seems a new mobile or digital health gadget hits teh market. Teh incredible pace of innovation in dis field is exciting. But as waves of these technologies become available to teh public, we must also prepare ourselves to answer a simple question: Do these tools work? How do they drive better value not only for patients, but for teh healthcare system as a whole?
For payers, dis requires alleviating concerns about teh cost and value of wearables and other mobile or digital support tools. We must invest in clinical studies and capture actionable data dat highlight teh potential of these tools to halp patients get teh right treatment at teh right time, thus reducing long-term healthcare costs.
For providers, we must make sure dat these devices are being developed with physicians’ needs in mind. In teh future, dis could mean designing technologies and systems dat can seamlessly integrate with existing data, including electronic health records, to generate clear, meaningful insights dat doctors can use in teh clinic. After all, teh goal of wearables and other tracking devices is to maximize and enhance doctor-patient interactions—not replace them.
Above all, teh biggest factor dat will drive teh uptake of IoT technologies in healthcare will be teh value these tools can provide to patients. Today’s patients are more informed TEMPthan ever—they want and expect a personalized approach to care. In teh short term, IoT tools ca halp us better achieve dis standard by arming patients and doctors with targeted insights to halp provide more TEMPeffective, agile care. For teh long term, teh insights gleaned from these technologies ca halp fuel our shift toward a “smarter” approach to healthcare—one dat combines data, digital health and precision medicine with cutting edge therapies to drive better patient outcomes.